What is the appropriate treatment for a ferritin level of 684 ng/mL?

Treatment for Ferritin 684 ng/mL

A ferritin of 684 ng/mL requires investigation to determine the underlying cause before initiating treatment, as this level is elevated and management depends entirely on whether this represents hereditary hemochromatosis, inflammation, chronic disease, or another etiology.

Clinical Context Determines Management

A ferritin of 684 ng/mL sits well above normal reference ranges but the appropriate treatment pathway diverges dramatically based on the underlying diagnosis:

If This Represents Hereditary Hemochromatosis

Initiate therapeutic phlebotomy immediately with the goal of iron depletion 1. The treatment protocol follows a structured two-phase approach:

Induction Phase

• Perform phlebotomy weekly or every 2 weeks (400-500 mL per session, adjusted for body weight and tolerance)
• Target ferritin of 50 μg/L to achieve iron depletion 1
• Monitor ferritin monthly initially, then every 1-2 sessions once ferritin drops below 200 μg/L 1
• Check hemoglobin at each session; reduce frequency if Hgb <12 g/dL, discontinue if <11 g/dL 1

Maintenance Phase (After Reaching Target)

• Phlebotomy every 1-4 months depending on iron accumulation rate
• Maintain ferritin in the range of 50-100 μg/L 1
• More relaxed targets (<200 μg/L for women, <300 μg/L for men) may be tolerated in elderly patients who poorly tolerate aggressive depletion 1
• Monitor ferritin every 6 months 1

Dietary Modifications (Adjunctive, Not Substitute)

• Avoid iron supplementation and iron-fortified foods 1
• Avoid supplemental vitamin C, especially before iron depletion 1
• Limit red meat consumption 1
• Restrict alcohol during iron depletion; abstain completely if cirrhosis present 1

If This Represents Inflammation or Chronic Disease

Do not perform phlebotomy. Ferritin is an acute phase reactant and can be elevated due to inflammation, infection, malignancy, or chronic kidney disease independent of iron stores 2. In these contexts:

• Investigate for underlying inflammatory conditions (check CRP, evaluate for infection, malignancy, autoimmune disease)
• In chronic kidney disease patients, ferritin levels of 500-1200 ng/mL are commonly seen and not necessarily associated with increased mortality when controlled for malnutrition and inflammation 3, 2
• Treatment should address the underlying condition, not the ferritin level itself

Critical Diagnostic Steps Required

Before any treatment decision:

1. Obtain transferrin saturation (TSAT) - In hemochromatosis, TSAT is typically >45-50% even when ferritin is elevated 1
2. Check inflammatory markers (CRP, ESR) - Elevated markers suggest ferritin elevation is inflammatory rather than true iron overload 2
3. Genetic testing for HFE mutations (C282Y, H63D) if hemochromatosis suspected
4. Assess for secondary causes: chronic liver disease, alcohol use, metabolic syndrome, chronic kidney disease, malignancy

Common Pitfalls to Avoid

• Do not assume elevated ferritin equals iron overload - Ferritin can be elevated from inflammation, making it an unreliable marker of iron stores in the presence of inflammatory conditions 2
• Do not use single ferritin values in isolation - Significant interassay variability exists (up to 150 ng/mL difference between assays) and intraindividual variability ranges 2-62% 4, 5
• Do not over-treat with phlebotomy - Aggressive phlebotomy targeting ferritin <20 μg/L can cause symptomatic iron deficiency even in hemochromatosis patients 1
• Monitor hemoglobin closely during phlebotomy to prevent anemia 1

Quality of Life Considerations

In confirmed hemochromatosis, early and adequate iron depletion through phlebotomy prevents progression to cirrhosis, diabetes, cardiomyopathy, and arthropathy - all of which significantly impact morbidity and mortality. However, the underlying cause must be correctly identified, as inappropriate phlebotomy in inflammatory conditions provides no benefit and may cause harm.